This invention relates to pyrrolocarbazole derivatives according formula I wherein R1, R2, R7, R8, R9, X and Y are as defined in the specification wherein said derivatives specifically inhibit one or both of the checkpoint kinases Wee1 and Chk1
本发明涉及公式I中的
吡咯烷并
咔唑衍
生物,其中R1、R2、R7、R8、R9、X和Y如规范中所定义,其中这些衍
生物特异性抑制检查点激酶Wee1和Chk1中的一个或两个。